Liquid chromatography-tandem mass spectrometry method for quantification of gentamicin and its individual congeners in serum and comparison results with two immunoanalytical methods (fluorescence polarization immunoassay and chemiluminiscent microparticle immunoassay)

被引:5
|
作者
Brozmanova, Hana [1 ,2 ]
Urinovska, Romana [1 ,2 ]
Safarcik, Kristian [3 ,4 ]
Vsiansky, Frantisek [3 ]
Kacirova, Ivana [1 ,2 ]
Grundmann, Milan [1 ]
机构
[1] Univ Ostrava, Fac Med, Inst Clin Pharmacol, Syllabova 19, Ostrava 70300, Czech Republic
[2] Univ Hosp Ostrava, Dept Clin Pharmacol, Dept Lab Med, 17 Listopadu 1790, Ostrava 70852, Czech Republic
[3] Univ Hosp Ostrava, Dept Clin Biochem, Dept Lab Med, 17 Listopadu 1790, Ostrava 70852, Czech Republic
[4] Univ Ostrava, Fac Med, Dept Biomed Sci, Syllabova 19, Ostrava 70300, Czech Republic
关键词
Total gentamicin concentration; LC-MS/MS; Fluorescence polarization immunoassay; Chemiluminiscence microparticle immunoassay; Therapeutic drug monitoring; PLASMA; VANCOMYCIN; AMIKACIN; TISSUES; SAMPLES; URINE;
D O I
10.1016/j.cca.2021.07.014
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Total gentamicin is a sum of five congeners C1, C1a, C2, C2a and minor C2b, which differ from each other in their methylation on the purpurosamine ring. Liquid chromatography with mass detection (LC-MS/MS) and specified calibration material enables the concentration of total gentamicin and its individual congeners to be analysed. Methods: 50 mu L serum was precipitated with acetonitrile in the presence of 0.5 mol/L formic acid. A RP BEH C18 1.7 mu m 2.1x50 mm column maintained at 30 degrees C and tobramicin as the internal standard were used. Mass detection was performed in positive electrospray. The gentamicin results were compared with fluorescence polarization immunoassay (FPIA) and chemiluminiscent microparticle immunoassay (CMIA). Passing-Bablock regression analysis and Bland-Altman analysis were used. Results: Calibration curves for individual gentamicin congeners were linear with correlation coefficients between 0.997 and 0.998. Recovery was 91.6-102.0% and the coefficients of variation 1.4-8.4%. The total gentamicin concentration was compared with immunoassay FPIA (LC-MSgen = 0.9798xPFIA(gen)) and CMIA (LC MSgen = 0.9835xCMIA(gen)) both with significant correlation (p < 0.001). Conclusion: The LC-MS/MS method is fast and precise and can be applied to routine TDM in patients. Comparing it to immunoassays makes it possible to measure concentration of gentamicin congeners, which may be important in the case of their different pharmacokinetics.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 50 条
  • [31] Determination of Lysergic Acid Diethylamide and 2-Oxo-3-Hydroxy-LSD in Blood: Validation and Comparison of Two Liquid Chromatography-Tandem Mass Spectrometry Methods
    Dimitrova, Alexandra
    Di Milia, Maria Grazia
    Rensi, Regina
    Grassi, Simone
    Gualco, Barbara
    Vaiano, Fabio
    SEPARATIONS, 2023, 10 (09)
  • [32] Quantification of three neurotransmitters in cerebrospinal fluid, serum and random urine using a robust and simplified liquid chromatography-tandem mass spectrometry method
    Zhong, Jian
    Guan, Lihua
    Zou, Yutong
    Yu, Jialei
    Ma, Xiaoli
    Liu, Ruichen
    Yu, Songlin
    Qiu, Ling
    JOURNAL OF CHROMATOGRAPHY A, 2025, 1747
  • [33] High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification of Carbamazepine, Oxcarbazepine, and Their Main Metabolites in Human Serum
    Lionetto, Luana
    Casolla, Barbara
    Cavallari, Michele
    Tisei, Paolo
    Buttinelli, Carla
    Simmaco, Maurizio
    THERAPEUTIC DRUG MONITORING, 2012, 34 (01) : 53 - 58
  • [34] Comparison of SemiQuantitative Cotinine Values Obtained by the DRI Immunoassay and Values Obtained by a Liquid Chromatography-Tandem Mass Spectrometry-Based Method: The DRI Immunoassay is Suitable for Screening Purposes Only Because Semiquantitative Values May Be Unreliable
    Dixon, R. Brent
    Dasgupta, Amitava
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2016, 30 (06) : 1106 - 1109
  • [35] Liquid chromatography-tandem mass spectrometry method for determining tolvaptan and its nine metabolites in rat serum: application to a pharmacokinetic study
    Furukawa, Masayuki
    Miyata, Kenichi
    Kawasome, Chie
    Himeda, Yoshiko
    Takeuchi, Kenji
    Koga, Toshihisa
    Hirao, Yukihiro
    Umehara, Ken
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (12) : 1578 - 1587
  • [36] Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay
    van den Ouweland, Johannes M. W.
    Beijers, Antonius M.
    Demacker, Pierre N. M.
    van Daal, Henny
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (15-16): : 1163 - 1168
  • [37] Liquid chromatography-tandem mass spectrometry method for identification and quantification of two biologically active polyisoprenylated benzophenones, isoxanthochymol and camboginol, in Garcinia species
    Chattopadhyay, Sunil K.
    Kumar, Satyanshu
    BIOMEDICAL CHROMATOGRAPHY, 2007, 21 (11) : 1159 - 1165
  • [38] Development, validation and long-term evaluation of a liquid chromatography-tandem mass spectrometry method for simultaneous quantification of amiodarone, desethylamiodarone and mexiletine in human plasma and serum
    Braakhuis, Martinus W. A.
    Pistorius, Marcel C. M.
    Postema, Pieter G.
    Hollak, Carolina E. M.
    Swart, Eleonora L.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2024, 1243
  • [39] Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of urapidil and aripiprazole in human plasma and its application to human pharmacokinetic study
    Ambavaram, Vijaya Bhaskar Reddy
    Nandigam, Venugopal
    Vemula, Madhavi
    Kalluru, Gangadhara Reddy
    Gajulapalle, Madhavi
    BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (07) : 916 - 923
  • [40] Highly sensitive liquid chromatography-tandem mass spectrometry method for quantification of a new bone anabolic agent, TAK-778, in human serum
    Teshima, K
    Kondo, T
    Maeda, C
    Oda, T
    Hagimoto, T
    Tsukuda, R
    Yoshimura, Y
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (02) : 299 - 305